一个多学科的方法与免疫疗法用于晚期肝细胞癌的免疫疗法
1Department of Internal Medicine, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Korea.
Journal of liver cancer
|September 24, 2023
概括
先进的肝细胞癌 (HCC) 治疗正在通过免疫疗法组合得到改善,提供更好的生存率. 为了在HCC治疗中进行最佳选择和新型药物,需要进一步的研究.
科学领域:
- 肝细胞癌 (HCC) 研究研究
- 医学瘤学 医学瘤学
- 免疫治疗是一种免疫疗法.
背景情况:
- 肝细胞癌 (HCC) 是癌症死亡的主要原因,通常在晚期诊断,治疗选择有限.
- 氨酸激酶抑制剂提供了适度的生存益处,但新的策略对于改善高级HCC的结果至关重要.
- 最近的进展集中在基于免疫疗法的治疗方法上,在提高生存率方面显示出显著的前景.
研究的目的:
- 审查目前基于免疫疗法的综合治疗,以治疗先进的HCC.
- 提出关于免疫检查点抑制剂 (ICI) 组合在先进的HCC.临床数据.
- 强调最佳HCC治疗选择和测序所需的多学科方法.
主要方法:
- 审查最近的临床试验和关于免疫疗法组合的数据对先进的HCC.
- 分析治疗方案,包括免疫检查点抑制剂 (ICI),抗血管新生药物和局部区域疗法.
- 从多学科的角度综合发现.
主要成果:
- 免疫疗法组合,特别是阿特佐利祖马布-贝瓦齐祖马布和杜尔瓦卢马布-特雷梅卢马布 (STRIDE),在晚期HCC中显著改善了存活率.
- 这些组合疗法正在为先进的HCC的第一线治疗制定新的护理标准.
- 结合治疗的协同效应比传统疗法提供了更好的结果.
结论:
- 综合免疫疗法方法在治疗先进的HCC方面取得了重大进展.
- 持续的研究对于优化治疗选择,识别生物标志物和开发新型免疫治疗剂至关重要.
- 为了最大限度地发挥当前和未来HCC治疗的好处,一个多学科的策略是必不可少的.
相关概念视频
01:27Tumor Immunotherapy
551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:30Cancer Vaccines
396
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
396